NeuroOne® to Report Fourth Quarter and Fiscal Year 2022 Financial Results and Provide Corporate Update on December 13
EDEN PRAIRIE, Minn., Dec. 8, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call to discuss financial results for its fiscal fourth quarter and full fiscal year ended September 30, 2022, and provide a corporate update, on December 13, 2022 at 4:30 PM Eastern Time.
Conference Call and Webcast Information:
Tuesday, December 13, 2022 – 4:30 PM Eastern Time
Participant Dial-In:
877-407-8293 / +1 201-689-8349
Live Webcast:
Join here
Phone Replay:
877-660-6853 / 201-612-7415, Access ID: 13734879; available through December 27, 2022
Webcast Replay:
Available for 12 months
NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders that may improve patient outcomes and reduce procedural costs. For more information, visit n1mtc.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/neuroone-to-report-fourth-quarter-and-fiscal-year-2022-financial-results-and-provide-corporate-update-on-december-13-301698053.html
SOURCE NeuroOne Medical Technologies Corporation
